REG-Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 126,322 of its own shares between October 5 and October 9, 2026, under the buyback program announced June 9, 2026. The purchases totaled €3,317,407.94 at an average price of €26.26, executed via a discretionary mandate to an independent financial intermediary across Euronext venues.
Key figures
- Period
- 2026-10-05 to 2026-10-09
- Average price eur
- 26.26
- Shares held total
- 1877353
- Shares repurchased
- 126322
- Lowest price paid eur
- 25.78
- Highest price paid eur
- 26.78
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.